<!DOCTYPE HTML PUBLIC "mits8">
<html>

<head>
<title>mits8</title>
<meta name="HandheldFriendly" content="true">
</head>

<body bgcolor="#ffffff">

<p><a name="page_1"></a></p>

<p align="center"><b><font size="2" face="serif">SECURITIES AND EXCHANGE COMMISSION </font></b></p>

<p align="center"><b><font size="2" face="serif">Washington, D.C. 20549 </font></b></p>

<p align="center"><b><font size="2" face="serif">FORM S-8 </font></b></p>

<p align="center"><b><font size="2" face="serif">REGISTRATION STATEMENT under THE
SECURITIES ACT OF 1933 </font></b></p>

<p align="center"><b><font size="2" face="serif"><u>Medical International Technology, Inc.</u>
</font></b></p>

<p align="center"><font size="2" face="serif">(Exact name of registrant as specified in
charter) </font></p>

<p><font size="2" face="serif">Colorado (State or other jurisdiction of incorporation or
organization)</font> </p>

<p><font size="2" face="serif">84-1509950 (IRS Employer Identification No.) </font></p>

<p align="center"><font size="2" face="serif">2281 Guenette, Ville Saint-Laurent Montreal,
Quebec, Canada HR4 2E9 </font></p>

<p align="center"><font size="2" face="serif">(Address of principal executive offices and
Zip Code) </font></p>

<p align="center"><font size="2" face="serif"><u>Medical International Technology Stock
Compensation Plan 2004</u> </font></p>

<p align="center"><font size="2" face="serif">(Full title of the plan) </font></p>

<p><font size="2" face="serif">Karim Menassa </font></p>

<p><font size="2" face="serif">2281 Guenette, Ville Saint-Laurent. </font></p>

<p><u><font size="2" face="serif">Montreal, Quebec, Canada HR4 2E9 </font></u></p>

<p><font size="2" face="serif">(Name and address of agent for service)</font> </p>

<p><font size="2" face="serif">(514) 339-9355 </font></p>

<p><font size="2" face="serif">(Telephone number of agent for service) </font></p>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td align="center"></td>
    <td align="center" colspan="7" width="44%"><b><font size="2" face="serif">CALCULATION OF
    REGISTRATION FEE</font></b></td>
    <td width="3%"></td>
    <td align="center" colspan="2" width="10%"></td>
    <td width="3%"></td>
  </tr>
  <tr>
    <td></td>
    <td colspan="7"><hr noshade size="1">
    </td>
    <td></td>
    <td colspan="2"></td>
    <td></td>
  </tr>
  <tr>
    <td>&nbsp;&nbsp;&nbsp;<font size="2" face="serif">Title of each class of</font></td>
    <td width="19%"><font size="2" face="serif">Amount to be</font></td>
    <td width="3%"></td>
    <td colspan="2" width="8%"><font size="2" face="serif">Proposed maximum</font></td>
    <td width="3%"></td>
    <td colspan="2" width="13%"><font size="2" face="serif">Proposed maximum</font></td>
    <td width="3%"></td>
    <td colspan="2" width="10%"><font size="2" face="serif">Amount of</font></td>
    <td width="3%"></td>
  </tr>
  <tr>
    <td><font size="2" face="serif">securities to be registered</font></td>
    <td width="19%"><font size="2" face="serif">registered</font></td>
    <td width="3%"></td>
    <td colspan="2" width="8%"><font size="2" face="serif">offering price per share</font></td>
    <td width="3%"></td>
    <td colspan="2" width="13%"><font size="2" face="serif">aggregate offering price</font></td>
    <td width="3%"></td>
    <td colspan="2" width="10%"><font size="2" face="serif">registration fee</font></td>
    <td width="3%"></td>
  </tr>
  <tr>
    <td><hr noshade size="1">
    </td>
    <td><hr noshade size="1">
    </td>
    <td></td>
    <td colspan="2"><hr noshade size="1">
    </td>
    <td></td>
    <td colspan="2"><hr noshade size="1">
    </td>
    <td></td>
    <td colspan="2"><hr noshade size="1">
    </td>
    <td></td>
  </tr>
  <tr>
    <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><font size="2" face="serif">Common Shares</font></b></td>
    <td width="19%"><b><font size="2" face="serif">2,000,000</font></b></td>
    <td width="3%"></td>
    <td width="2%"><b><font size="2" face="serif">$</font></b></td>
    <td width="7%"><font size="2" face="serif"><b>0.11</b></font></td>
    <td width="3%"></td>
    <td width="2%"><b><font size="2" face="serif">$</font></b></td>
    <td width="11%"><font size="2" face="serif"><b>220,000</b></font></td>
    <td width="3%"></td>
    <td width="2%"><b><font size="2" face="serif">$</font></b></td>
    <td width="8%"><font size="2" face="serif"><b>27.87</b></font></td>
    <td width="3%"></td>
  </tr>
</table>

<p><font size="1" face="serif">Note: Proposed maximum offering price per share and
Proposed maximum aggregate offering price estimated solely for the purpose of calculating
the registration fee pursuant to Rule 457. </font></p>

<p align="center"><font size="2" face="serif">I </font></p>

<hr noshade align="center" width="100%" size="2">

<p><a name="page_2"></a></p>

<p><font size="2" face="serif"><u>Medical International Technology, Inc. - Form S-8</u> </font></p>

<p align="center"><b><font size="2" face="serif">PART I </font></b></p>

<p align="center"><b><font size="2" face="serif">INFORMATION REQUIRED IN THE PROSPECTUS </font></b></p>

<p><font size="2" face="serif">Note: The document(s) containing the information concerning
the Medical International Technology Stock Compensation Plan 2004 (the &quot;Plan&quot;)
of Medical International Technology, Inc., a Colorado corporation (the
&quot;Registrant&quot; or the &quot;Company&quot;), dated July 29, 2004 required by Item 1
of Form S-8 under the Securities Exchange Act of 1934, as amended (the &quot;Exchange
Act&quot;), and the statement of availability of registrant information, employee benefit
plan annual reports and other information required by Item 2 of Form S-8 will be sent or
given to participants as specified in Rule 428. In accordance with Rule 428 and the
requirements of Part I of Form S-8, such documents are not being filed with the Securities
and Exchange Commission (the &quot;Commission&quot;) either as part of this registration
statement on Form S-8 (the &quot;Registration Statement&quot;) or as prospectuses or
prospectus supplements pursuant to Rule 424. The Company will maintain a file of such
documents in accordance with the provisions of Rule 428. Upon request, the Company shall
furnish to the Commission or its staff a copy or copies of all of the documents included
in such file. </font></p>

<p align="center"><b><font size="2" face="serif">PART II </font></b></p>

<p align="center"><b><font size="2" face="serif">INFORMATION REQUIRED IN THE REGISTRATION
STATEMENT </font></b></p>

<p><b><font size="2" face="serif">Item 3. Incorporation of Documents by Reference. </font></b></p>

<p><font size="2" face="serif">The following documents, which have been filed by the
Company with the Securities and Exchange Commission, are hereby incorporated by reference:
</font></p>

<p><font size="2" face="serif">a. The Company's Annual Report on Form 10-KSB for the
fiscal year ended September 30, 2003; </font></p>

<p><font size="2" face="serif">b. The Company's Quarterly Reports on Form 10-QSB for the
fiscal quarters ended December 31, 2003, and March 31, 2004. </font></p>

<p><font size="2" face="serif">All documents filed by the Company with the Commission
pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date
of this Registration Statement and prior to the filing of a post-effective amendment to
this Registration Statement which indicates that all securities offered hereby have been
sold or which deregisters all securities then remaining unsold shall be deemed to be
incorporated in this Registration Statement by reference and to be a part hereof from the
date of filing of such documents. </font></p>

<p><font size="2" face="serif">Any statement contained in this Registration Statement, in
a supplement to this Registration Statement or in a document incorporated by reference
herein, shall be deemed to be modified or superseded for purposes of this Registration
Statement to the extent that a statement contained herein or in any subsequently filed
supplement to this Registration Statement or in any document that is subsequently
incorporated by reference herein modifies or supersedes such statement. Any statement so
modified or superseded shall not be deemed, except as so modified or superseded, to
constitute a part of this Registration Statement. </font></p>

<p align="center"><font size="2" face="serif">Page 2 </font></p>

<hr noshade align="center" width="100%" size="2">

<p><a name="page_3"></a></p>

<p><font size="2" face="serif"><u>Medical International Technology, Inc. - Form S-8</u> </font></p>

<p><b><font size="2" face="serif">Item 4. Description of Securities. </font></b></p>

<p><font size="2" face="serif">The Company's authorized capital consists of 100,000,000
shares of Common Stock, $.0001 par value and 3,000,000 shares of Preferred stock, par
value $.001, of which 25,170,400 common shares were outstanding as of March 31, 2004. No
Preferred shares have been issued. </font></p>

<p><font size="2" face="serif">The Company's common stock is presently listed and traded
on the NASD's Over-The-Counter Bulletin Board exchange under the symbol &quot;MDIR&quot;.</font>
</p>

<p><font size="2" face="serif"><u>Common Stock</u> </font></p>

<p><font size="2" face="serif">Each share of Common Stock is entitled to one vote, either
in person or by proxy, on all matters that may be voted upon by the owners thereof at a
meeting of the shareholders, including the election of directors. The holders of Common
Stock (i) have equal, ratable rights to dividends from funds legally available therefore,
when, as and if declared by the Board of Directors of the Company; (ii) are entitled to
share ratably in all of the assets of the Company available for distribution to holders of
Common Stock upon liquidation, dissolution or winding up of the affairs of the Company;
(iii) do not have preemptive or redemption provisions applicable thereto; and (iv) are
entitled to one non cumulative vote per share on all matters on which shareholders may
vote at all meetings of shareholders. </font></p>

<p><font size="2" face="serif">All shares of Common Stock issued and outstanding are, and
those offered hereby, when issued, will be fully paid and nonassessable, with no personal
liability attaching to the ownership thereof. </font></p>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td><font size="2" face="serif">Transfer Agent</font></td>
  </tr>
  <tr>
    <td><hr noshade size="1">
    </td>
  </tr>
  <tr>
    <td>&nbsp;&nbsp;&nbsp;<font size="2" face="serif">Corporate Stock Transfer</font></td>
  </tr>
  <tr>
    <td>&nbsp;&nbsp;&nbsp;<font size="2" face="serif">3200 Cherry Creek Road South, Suite 430</font></td>
  </tr>
  <tr>
    <td>&nbsp;&nbsp;&nbsp;<font size="2" face="serif">Denver, CO 80209</font></td>
  </tr>
</table>

<p><b><font size="2" face="serif">Item 5. Interests of Named Experts and Counsel. </font></b></p>

<p><font size="2" face="serif">As of the date of this registration no named expert or
counsel holds any specified interest or significant equity in the company.</font> </p>

<p align="center"><font size="2" face="serif">Page 3 </font></p>

<hr noshade align="center" width="100%" size="2">

<p><a name="page_4"></a></p>

<p><font size="2" face="serif"><u>Medical International Technology, Inc. - Form S-8</u> </font></p>

<p><b><font size="2" face="serif">Item 6. Indemnification of Directors and Officers. </font></b></p>

<p><font size="2" face="serif">The Company's Articles of Incorporation authorizes the
Corporation to indemnify to the maximum extent permitted under Colorado law. </font></p>

<p><font size="2" face="serif">The Colorado Private Corporations Act allows
indemnification of directors, officers, employees and agents of the Company, including the
advancement of expenses: Every person who was or is a party or is threatened to be made a
party to or is involved in any action, suit or proceeding, whether civil, criminal,
administrative or investigative, by reason of the fact that he or a person of whom he is
the legal representative is or was a director or officer of the corporation or is or was
serving at the request of the corporation for its benefit as a director or officer of
another corporation, or as its representative in a partnership, joint venture, trust or
other enterprise, shall be indemnified and held harmless to the fullest extent legally
permissible under the general corporation law of the State of Colorado from time to time
against all expenses, liability and loss (including attorney's fees, judgments, fines, and
amounts paid or to be paid in settlement) reasonably incurred and in advance of the final
disposition of the action, suit or proceeding upon receipt of an undertaking by or on
behalf of the director or officer to repay the amount if it is ultimately determined by a
court of competent jurisdiction that he is not entitled to be indemnified by the
corporation. Such right of indemnification shall be a contract right which may be enforced
in any manner desired by such person; and shall not be exclusive of any other right which
such directors, officers or representatives may have or hereafter acquire and, without
limiting the generality of such statement, they shall be entitled to their respective
rights of indemnification under any bylaw, agreement, vote of stockholders, provision of
law or otherwise, as well as their rights under the Articles of Incorporation of Medical
International Technology, Inc.. </font></p>

<p><font size="2" face="serif">In general, officers and directors of Registrant are
indemnified against expenses actually and reasonably incurred in connection with
proceedings, whether civil or criminal, provided that it is determined that they acted in
good faith, and are not deemed to be liable to Registrant for negligence or misconduct in
the performance of their duties. </font></p>

<p align="center"><font size="2" face="serif">Page 4 </font></p>

<hr noshade align="center" width="100%" size="2">

<p><a name="page_5"></a></p>

<p><font size="2" face="serif"><u>Medical International Technology, Inc. - Form S-8</u> </font></p>

<p><b><font size="2" face="serif">Item 7. Exemption from Registration Claimed. </font></b></p>

<p><font size="2" face="serif">Not Applicable. </font></p>

<p><b><font size="2" face="serif">Item 8. Exhibits. </font></b></p>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="15%"><font size="2" face="serif">Exhibit Number</font></td>
    <td width="86%"><font size="2" face="serif">Description</font></td>
  </tr>
  <tr>
    <td><hr noshade size="1">
    </td>
    <td><hr noshade size="1">
    </td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td width="15%"><font size="2" face="serif">4</font></td>
    <td width="86%"><font size="2" face="serif">Medical International Technology Stock
    Compensation Plan 2004 dated July 29, 2004.</font></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td width="15%"><font size="2" face="serif">5</font></td>
    <td width="86%"><font size="2" face="serif">Opinion of Counsel, Randall J. Lanham, Lanham
    &amp; Associates</font></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td width="15%"><font size="2" face="serif">23.1</font></td>
    <td width="86%"><font size="2" face="serif">Consent of Certified Public Accountants</font></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td width="15%"><font size="2" face="serif">23.2</font></td>
    <td width="86%"><font size="2" face="serif">Consent of Randall J. Lanham, Lanham &amp;
    Associates</font></td>
  </tr>
  <tr>
    <td width="15%"></td>
    <td width="86%"><font size="2" face="serif">(included in Exhibit 5)</font></td>
  </tr>
</table>

<p><b><font size="2" face="serif">Item 9. Undertakings </font></b></p>

<p><font size="2" face="serif">1.</font>&nbsp;<font size="2" face="serif">The Registrant
hereby undertakes: </font></p>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td><font size="2" face="serif">(a)</font></td>
    <td width="98%"><font size="2" face="serif">To file, during any period in which offers or
    sales are being made, a post-effective amendment to this</font></td>
  </tr>
  <tr>
    <td></td>
    <td width="98%"><font size="2" face="serif">registration statement:</font></td>
  </tr>
</table>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td><font size="2" face="serif">(i)</font></td>
    <td width="97%"><font size="2" face="serif">to include any prospectus required by Section
    10(a)(3) of the Securities Act of 1933;</font></td>
  </tr>
  <tr>
    <td><font size="2" face="serif">(ii)</font></td>
    <td width="97%"><font size="2" face="serif">to reflect in the prospectus any facts or
    events arising after the effective date of the registration</font></td>
  </tr>
  <tr>
    <td></td>
    <td width="97%"><font size="2" face="serif">statement (or the most recent post-effective
    amendment thereof) which, individually or in the</font></td>
  </tr>
  <tr>
    <td></td>
    <td width="97%"><font size="2" face="serif">aggregate, represent a fundamental change in
    the formation set forth in the registration statement;</font></td>
  </tr>
  <tr>
    <td colspan="2" width="101%"><font size="2" face="serif">(iii) to include any material
    information with respect to a plan of distribution not previously disclosed in the</font></td>
  </tr>
  <tr>
    <td></td>
    <td width="97%"><font size="2" face="serif">registration statement or any material change
    to such information in the registration statement;</font></td>
  </tr>
</table>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td><font size="2" face="serif">(b)</font></td>
    <td width="98%"><font size="2" face="serif">That, for the purpose of determining any
    liability under the Securities Act of 1933, each such post-effective</font></td>
  </tr>
  <tr>
    <td></td>
    <td width="98%"><font size="2" face="serif">amendment shall be deemed to be a new
    registration statement relating to the securities offered therein, and</font></td>
  </tr>
  <tr>
    <td></td>
    <td width="98%"><font size="2" face="serif">the offering of such securities at that time
    shall be deemed to be the initial bonafide offering thereof.</font></td>
  </tr>
  <tr>
    <td><font size="2" face="serif">(c)</font></td>
    <td width="98%"><font size="2" face="serif">To remove from registration by means of a
    post-effective amendment any of the securities being registered</font></td>
  </tr>
  <tr>
    <td></td>
    <td width="98%"><font size="2" face="serif">which remain unsold at the termination of the
    offering.</font></td>
  </tr>
</table>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="2%"><font size="2" face="serif">2.</font></td>
    <td width="99%"><font size="2" face="serif">The Registrant hereby undertakes that, for
    purposes of determining any liability under the Securities Act of</font></td>
  </tr>
  <tr>
    <td width="2%"></td>
    <td width="99%"><font size="2" face="serif">1933, each filing of the Registrant's annual
    report pursuant to Section 13(a) or Section 15(d) of the Exchange</font></td>
  </tr>
  <tr>
    <td width="2%"></td>
    <td width="99%"><font size="2" face="serif">Act (and, where applicable, each filing of an
    employee benefit plan's annual report pursuant to Section 15(d) of</font></td>
  </tr>
  <tr>
    <td width="2%"></td>
    <td width="99%"><font size="2" face="serif">the Exchange Act) that is incorporated by
    reference in the registration statement shall be deemed to be a new</font></td>
  </tr>
  <tr>
    <td width="2%"></td>
    <td width="99%"><font size="2" face="serif">registration statement relating to the
    securities offered herein, and the offering of such securities at that time</font></td>
  </tr>
  <tr>
    <td width="2%"></td>
    <td width="99%"><font size="2" face="serif">shall be deemed to be in the initial bona fide
    offering thereof.</font></td>
  </tr>
</table>

<p align="center"><font size="2" face="serif">Page 5 </font></p>

<hr noshade align="center" width="100%" size="2">

<p><a name="page_6"></a></p>

<p><font size="2" face="serif"><u>Medical International Technology, Inc. - Form S-8</u> </font></p>

<p align="center"><b><font size="2" face="serif">SIGNATURES </font></b></p>

<p><font size="2" face="serif">Pursuant to the requirements of the Securities Act of 1933,
Registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly authorized, in the City of
Montreal, Quebec, Canada, on this 4th day of July, 2004. </font></p>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td><font size="2" face="serif">Medical International Technology, Inc.</font></td>
  </tr>
  <tr>
    <td></td>
  </tr>
  <tr>
    <td><font size="2" face="serif">By: \S\ Karim Menassa</font></td>
  </tr>
  <tr>
    <td colspan="1"><hr noshade size="1">
    </td>
  </tr>
  <tr>
    <td><font size="2" face="serif">President and CEO</font></td>
  </tr>
</table>

<p><font size="2" face="serif">In accordance with the requirements of the Securities Act
of 1933 as amended, this Registration Statement has been signed by the following persons
in the capacities and on the date indicated. </font></p>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td></td>
    <td width="21%"><font size="2" face="serif">SIGNATURE</font></td>
    <td width="53%"><font size="2" face="serif">TITLE</font></td>
    <td width="24%"><font size="2" face="serif">DATE</font></td>
  </tr>
  <tr>
    <td></td>
    <td><hr noshade size="1">
    </td>
    <td><hr noshade size="1">
    </td>
    <td><hr noshade size="1">
    </td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td><font size="2" face="serif">\S\</font></td>
    <td width="21%"><font size="2" face="serif">Karim Menassa</font></td>
    <td width="53%"><font size="2" face="serif">Chief Executive Officer, President</font></td>
    <td width="24%"><font size="2" face="serif">August 23, 2004</font></td>
  </tr>
  <tr>
    <td><hr noshade size="1">
    </td>
    <td><hr noshade size="1">
    </td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td><font size="2" face="serif">\S\</font></td>
    <td width="21%"><font size="2" face="serif">Michel Bayouk</font></td>
    <td width="53%"><font size="2" face="serif">Chief Financial Officer, Secretary</font></td>
    <td width="24%"><font size="2" face="serif">August 23, 2004</font></td>
  </tr>
  <tr>
    <td><hr noshade size="1">
    </td>
    <td><hr noshade size="1">
    </td>
    <td></td>
    <td></td>
  </tr>
</table>

<p align="center"><font size="2" face="serif">Page 6 </font></p>

<hr noshade align="center" width="100%" size="2">
</body>
</html>
[{"type": "S-8", "sequence": "1", "filename": "mits8.htm", "description": "S-8", "secsgml_size_bytes": 23298}, {"type": "S-8", "sequence": "2", "filename": "mits8.pdf", "description": "S-8", "secsgml_size_bytes": 249672}]
{"company-data": {"conformed-name": "MEDICAL INTERNATIONAL TECHNOLOGY INC", "cik": "0001112372", "assigned-sic": "3841", "irs-number": "841509950", "state-of-incorporation": "CO", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-118538", "film-number": "04996212"}, "business-address": {"street1": "2281 GUENETTE", "street2": ".", "city": "VILLE SAINT-LAURENT", "state": "A8", "zip": "HR4 2E9", "phone": "(514) 339-9355"}, "mail-address": {"street1": "2281 GUENETTE", "street2": ".", "city": "VILLE SAINT-LAURENT", "state": "A8", "zip": "HR4 2E9"}, "former-company": {"former-conformed-name": "POSTERALLEY COM INC", "date-changed": "20000824"}}
mits8
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT under THE
SECURITIES ACT OF 1933
Medical International Technology, Inc.
(Exact name of registrant as specified in
charter)
Colorado (State or other jurisdiction of incorporation or
organization)
84-1509950 (IRS Employer Identification No.)
2281 Guenette, Ville Saint-Laurent Montreal,
Quebec, Canada HR4 2E9
(Address of principal executive offices and
Zip Code)
Medical International Technology Stock
Compensation Plan 2004
(Full title of the plan)
Karim Menassa
2281 Guenette, Ville Saint-Laurent.
Montreal, Quebec, Canada HR4 2E9
(Name and address of agent for service)
(514) 339-9355
(Telephone number of agent for service)
CALCULATION OF
    REGISTRATION FEE
Title of each class of
Amount to be
Proposed maximum
Proposed maximum
Amount of
securities to be registered
registered
offering price per share
aggregate offering price
registration fee
Common Shares
2,000,000
$
0.11
$
220,000
$
27.87
Note: Proposed maximum offering price per share and
Proposed maximum aggregate offering price estimated solely for the purpose of calculating
the registration fee pursuant to Rule 457.
I
Medical International Technology, Inc. - Form S-8
PART I
INFORMATION REQUIRED IN THE PROSPECTUS
Note: The document(s) containing the information concerning
the Medical International Technology Stock Compensation Plan 2004 (the "Plan")
of Medical International Technology, Inc., a Colorado corporation (the
"Registrant" or the "Company"), dated July 29, 2004 required by Item 1
of Form S-8 under the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), and the statement of availability of registrant information, employee benefit
plan annual reports and other information required by Item 2 of Form S-8 will be sent or
given to participants as specified in Rule 428. In accordance with Rule 428 and the
requirements of Part I of Form S-8, such documents are not being filed with the Securities
and Exchange Commission (the "Commission") either as part of this registration
statement on Form S-8 (the "Registration Statement") or as prospectuses or
prospectus supplements pursuant to Rule 424. The Company will maintain a file of such
documents in accordance with the provisions of Rule 428. Upon request, the Company shall
furnish to the Commission or its staff a copy or copies of all of the documents included
in such file.
PART II
INFORMATION REQUIRED IN THE REGISTRATION
STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents, which have been filed by the
Company with the Securities and Exchange Commission, are hereby incorporated by reference:
a. The Company's Annual Report on Form 10-KSB for the
fiscal year ended September 30, 2003;
b. The Company's Quarterly Reports on Form 10-QSB for the
fiscal quarters ended December 31, 2003, and March 31, 2004.
All documents filed by the Company with the Commission
pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date
of this Registration Statement and prior to the filing of a post-effective amendment to
this Registration Statement which indicates that all securities offered hereby have been
sold or which deregisters all securities then remaining unsold shall be deemed to be
incorporated in this Registration Statement by reference and to be a part hereof from the
date of filing of such documents.
Any statement contained in this Registration Statement, in
a supplement to this Registration Statement or in a document incorporated by reference
herein, shall be deemed to be modified or superseded for purposes of this Registration
Statement to the extent that a statement contained herein or in any subsequently filed
supplement to this Registration Statement or in any document that is subsequently
incorporated by reference herein modifies or supersedes such statement. Any statement so
modified or superseded shall not be deemed, except as so modified or superseded, to
constitute a part of this Registration Statement.
Page 2
Medical International Technology, Inc. - Form S-8
Item 4. Description of Securities.
The Company's authorized capital consists of 100,000,000
shares of Common Stock, $.0001 par value and 3,000,000 shares of Preferred stock, par
value $.001, of which 25,170,400 common shares were outstanding as of March 31, 2004. No
Preferred shares have been issued.
The Company's common stock is presently listed and traded
on the NASD's Over-The-Counter Bulletin Board exchange under the symbol "MDIR".
Common Stock
Each share of Common Stock is entitled to one vote, either
in person or by proxy, on all matters that may be voted upon by the owners thereof at a
meeting of the shareholders, including the election of directors. The holders of Common
Stock (i) have equal, ratable rights to dividends from funds legally available therefore,
when, as and if declared by the Board of Directors of the Company; (ii) are entitled to
share ratably in all of the assets of the Company available for distribution to holders of
Common Stock upon liquidation, dissolution or winding up of the affairs of the Company;
(iii) do not have preemptive or redemption provisions applicable thereto; and (iv) are
entitled to one non cumulative vote per share on all matters on which shareholders may
vote at all meetings of shareholders.
All shares of Common Stock issued and outstanding are, and
those offered hereby, when issued, will be fully paid and nonassessable, with no personal
liability attaching to the ownership thereof.
Transfer Agent
Corporate Stock Transfer
3200 Cherry Creek Road South, Suite 430
Denver, CO 80209
Item 5. Interests of Named Experts and Counsel.
As of the date of this registration no named expert or
counsel holds any specified interest or significant equity in the company.
Page 3
Medical International Technology, Inc. - Form S-8
Item 6. Indemnification of Directors and Officers.
The Company's Articles of Incorporation authorizes the
Corporation to indemnify to the maximum extent permitted under Colorado law.
The Colorado Private Corporations Act allows
indemnification of directors, officers, employees and agents of the Company, including the
advancement of expenses: Every person who was or is a party or is threatened to be made a
party to or is involved in any action, suit or proceeding, whether civil, criminal,
administrative or investigative, by reason of the fact that he or a person of whom he is
the legal representative is or was a director or officer of the corporation or is or was
serving at the request of the corporation for its benefit as a director or officer of
another corporation, or as its representative in a partnership, joint venture, trust or
other enterprise, shall be indemnified and held harmless to the fullest extent legally
permissible under the general corporation law of the State of Colorado from time to time
against all expenses, liability and loss (including attorney's fees, judgments, fines, and
amounts paid or to be paid in settlement) reasonably incurred and in advance of the final
disposition of the action, suit or proceeding upon receipt of an undertaking by or on
behalf of the director or officer to repay the amount if it is ultimately determined by a
court of competent jurisdiction that he is not entitled to be indemnified by the
corporation. Such right of indemnification shall be a contract right which may be enforced
in any manner desired by such person; and shall not be exclusive of any other right which
such directors, officers or representatives may have or hereafter acquire and, without
limiting the generality of such statement, they shall be entitled to their respective
rights of indemnification under any bylaw, agreement, vote of stockholders, provision of
law or otherwise, as well as their rights under the Articles of Incorporation of Medical
International Technology, Inc..
In general, officers and directors of Registrant are
indemnified against expenses actually and reasonably incurred in connection with
proceedings, whether civil or criminal, provided that it is determined that they acted in
good faith, and are not deemed to be liable to Registrant for negligence or misconduct in
the performance of their duties.
Page 4
Medical International Technology, Inc. - Form S-8
Item 7. Exemption from Registration Claimed.
Not Applicable.
Item 8. Exhibits.
Exhibit Number
Description
4
Medical International Technology Stock
    Compensation Plan 2004 dated July 29, 2004.
5
Opinion of Counsel, Randall J. Lanham, Lanham
    & Associates
23.1
Consent of Certified Public Accountants
23.2
Consent of Randall J. Lanham, Lanham &
    Associates
(included in Exhibit 5)
Item 9. Undertakings
1.
The Registrant
hereby undertakes:
(a)
To file, during any period in which offers or
    sales are being made, a post-effective amendment to this
registration statement:
(i)
to include any prospectus required by Section
    10(a)(3) of the Securities Act of 1933;
(ii)
to reflect in the prospectus any facts or
    events arising after the effective date of the registration
statement (or the most recent post-effective
    amendment thereof) which, individually or in the
aggregate, represent a fundamental change in
    the formation set forth in the registration statement;
(iii) to include any material
    information with respect to a plan of distribution not previously disclosed in the
registration statement or any material change
    to such information in the registration statement;
(b)
That, for the purpose of determining any
    liability under the Securities Act of 1933, each such post-effective
amendment shall be deemed to be a new
    registration statement relating to the securities offered therein, and
the offering of such securities at that time
    shall be deemed to be the initial bonafide offering thereof.
(c)
To remove from registration by means of a
    post-effective amendment any of the securities being registered
which remain unsold at the termination of the
    offering.
2.
The Registrant hereby undertakes that, for
    purposes of determining any liability under the Securities Act of
1933, each filing of the Registrant's annual
    report pursuant to Section 13(a) or Section 15(d) of the Exchange
Act (and, where applicable, each filing of an
    employee benefit plan's annual report pursuant to Section 15(d) of
the Exchange Act) that is incorporated by
    reference in the registration statement shall be deemed to be a new
registration statement relating to the
    securities offered herein, and the offering of such securities at that time
shall be deemed to be in the initial bona fide
    offering thereof.
Page 5
Medical International Technology, Inc. - Form S-8
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933,
Registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereunto duly authorized, in the City of
Montreal, Quebec, Canada, on this 4th day of July, 2004.
Medical International Technology, Inc.
By: \S\ Karim Menassa
President and CEO
In accordance with the requirements of the Securities Act
of 1933 as amended, this Registration Statement has been signed by the following persons
in the capacities and on the date indicated.
SIGNATURE
TITLE
DATE
\S\
Karim Menassa
Chief Executive Officer, President
August 23, 2004
\S\
Michel Bayouk
Chief Financial Officer, Secretary
August 23, 2004
Page 6